Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_assertion type Assertion NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_head.
- NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_assertion wasGeneratedBy ECO_0000203 NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_provenance.
- NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_assertion wasDerivedFrom befree-20140225 NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_provenance.
- NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_assertion SIO_000772 15041728 NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_provenance.
- NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_assertion evidence source_evidence_literature NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_provenance.
- NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_assertion description "[Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763702.RA9srdE-U0oQL7SaBwVB-7RxkyNTuyBdbgMCoHNo07n0g130_provenance.